Ironwood Pharmaceuticals | IRWD - Le Bénéfice D'Exploitation

Prix De L'Action
3.65
Variation Quotidienne
0.02 0.55%
Mensuellement
8.31%
Annuel
463.36%
Q2 Prévisions
3.53




Le Bénéfice D'Exploitation Changement Date
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Almirall EUR 30.23M 12.8M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -2.26M 564K 2025-12
Ardelyx USD 5.1M 431K 2025-12
Astellas Pharma JPY 134.54B 30.13B 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Coherus Biosciences USD -39.08M 3.65M 2025-12
Emergent BioSolutions USD -218M 69.9M 2023-06
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 383.88M 47.43M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -17.84M 13.44M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
MacroGenics USD -12.1M 30.74M 2025-12
Moderna USD -857M 597M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 3.19M 9.96M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD 22.08M 24.26M 2024-09
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Takeda JPY 168.82B 479.89B 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12